Modulatory effects of rosemary leaves aqueous extract on doxorubicin-induced histological lesions, apoptosis and oxidative stress in mice

Iranian Journal of Cancer Prevention

Volumn 3, Issue 1, 2010, Pages 1-22

  Rasha, Ahmed R ^a   Abdella, E M ^a  

^a Beni Suef University   (Egypt)

Author keywords

Apoptotic marker (Box Bcl 2); Doxorubicin; Oxidative stress; Rosemary

Indexed keywords

DOXORUBICIN; ROSMARINUS OFFICINALIS EXTRACT;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; EXPERIMENTAL MOUSE; HEART; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TISSUE DEGENERATION; TISSUE INJURY;

MUS; ROSMARINUS OFFICINALIS;

EID: 77953450426     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Albrecht D, Geist A, Ketelsen U, Haberstroh J, Setzer B, Walker U. Dexrazoxane prevents doxorubicin-induced longterm cardio toxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br. J. Pharmacology. 2007; 151(6): 771-78.
2. Ogura M. Adriamycin (Doxorubicin). Ganto Kagaku Ryoho. 2001; 28 (10): 1331-38.
3. Andrieu-Abadie N, Jaffrézou J, Hatem S, Laurent G, Levade T, Mercadier J. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J. 1999; 13: 1501-10.
4. Kimura T, Fujita I, Nakanishi T, Itoh N, Muto N, Tanaka K. Effect of metallothionein on doxorubicin induced hepatotoxicity. J Health Sci. 1999; 45: 23.
5. Kato M, Makino S, Kimura H, Ota T, Furuhashi T, Nagamura Y. Sperm motion analysis in rats treated with adriamycin and its applicability to male reproductive toxicity studies. J. Toxicol. Sci. 2001; 26(1): 51-59.
6. Gillick J, Giles S, Baannigan J, Puri P. Cell death in the early Adriamycin rat model. Pediatric. Sur. Int. 2002; 18: 576-80.
7. Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin. Chim. Acta. 2004; 348 (1-2): 27-34.
8. Shizukuda Y, Motoba S, Mian O, Nguyen T, Twang P. Targeted distribution of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol. Cell Biochem. 2005; 273 (1-2): 25-32.
9. Kalender Y, Yel M, Kalender S. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: the effects of vitamin E and catechin. Toxicology. 2005; 209: 39-45.
10. Prahalathan C, Selvakumar E, Varalakshmi P, Kumarasamy P, Saravanan R. Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells. Toxicology. 2006; 15(3): 225-32.
11. Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardio toxicity and nephrotoxicity. Toxicology. 2006; 218: 164-171.
12. Abd-Ellah M, Mariee A. Ginko biloba leaf extract (EGb 761) diminishes adriamycin-induced hyperlipidaemic nephrotoxicity in rats: association with nitric oxide production. Biotechnology Appl Biochem. 2007; 46: 35-40.
13. Hida H, Coudray C, Calop J, Favier A. Effect of antioxidants on adriamycin-induced microsomal lipid per oxidation. Biol Trace Elem Res. 1995; 47: 111-16.
14. Pristos C, Ma J. Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity. Chem. Biol. Interact. 2000; 127: 1-11.
15. Saad S, Najjar T, Al-Rykaby A. The preventive role of deferoxamine against acute doxorubicin-induced cardiac renal and hepatic toxicity in rats. Pharmacology Res. 2001; 43: 211-218.
16. Quiles J, Huertas J, Battino M, Mataix J, Ramirez-Tortosa M. Antioxidant nutrients and Adriamycin toxicity. Toxicology. 2002; 180: 79-95.
17. Fadillioglu E, Erdogan H, Sogut S, Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomtocytes in rats. J Appl Toxicol. 2003; 23: 71-4.
18. Quin X, He W, Hai C, Liang X, Liu R. Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy. J Appl Toxicol. 2007; 28(3): 271-82.
19. Ho C, Ferraro T, Chen Q, Rosen R, Huang M. Phytochemicals in teas and rosemary and their cancer preventive properties. In: "Food Phytochemicals for Cancer Prevention". Ho C., Osawa T, Huang M and Rosen R (Eds). American Chemical Society Symposium Series 547 American Chemical Society Washington DC. 1994; pp. 2-19.
20. Samman S, Sandstrom B, Toft M, Mukhave K, Jensen M, Sorensen S, Hansen M. Green tea or rosemary extract added to food reduces nonheme-iron absorption. Am J Clin Nutr. 2000; 73: 607-12.
21. Válenzuela A, Sanhueza J, Alonso P, Corbari A, Nieto S. Inhibitory action of conventional food-grade natural antioxidants of new development on the thermal-induced oxidation of cholesterol. Int J Food Sci Nutr. 2004; 55: 155-62.
22. Inatani R, Nakatani N, Fuwa H. Antioxidative effect of the constituents of rosemary (Rosmarinus officinalis) and their derivatives. J Agric Biol Chem. 1983; 47: 521-8.
23. Aruoma O, Haliwell B, Aeschbach R, Loligers J. Antioxidant and pro-oxidant properties of active rosemary constituents carnosol and carnosoic acid. Xenobiotica. 1992; 22(2): 257-68.
24. Wu J, Lee M, Chang S. Elucidation of chemical structures of natural antioxidants isolated from rosemary. J Am Chem Soc. 1982; 59: 339-45.
25. Jadhav S, Nimbalkar S, Kulkarni A, Madhavi D. Food antioxidants: Lipid Oxidation in Biological and Food Systems. New York: Marcel Dekker; 1996, 5-63.
26. Jindal A, Soyal D, Sihgh I, Reszka R. Modification of radiation-induced damage in mice by Rosemarinus officinalis extracts (ROE). Pharmacology Line. 2006; 2: 63-75.
27. Kizaki K, Ito R, Okada M, Yoshioka K, Uchide T, Temma K, et al. Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice. Pharmacology Res. 2006; 53: 341-6.
28. Yagmurca M, Bas O, Mollaglu H, Sahin O, Nacar A, Karaman O, Songur A. Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats. Arch Med Res. 2007; 38: 380-5.
29. Pressus H, Jarrel S, Scheckenbach R, Lieberman S, Anderson R. Comparative effects of chromium vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr. 1998; 17(2): 116-23.
30. Arthur R, Boyne R. Superoxide dismutase and glutathione peroxidase activities in neutrophils selenium deficient and copper deficient cattle. Life Sciences. 1985; 36(16): 1569-75.
31. Beutler E, Duron O, Kelly B. Improved method for determination of blood glutathione. J Lab Clin Med. 1963; 61: 882-8.
32. Cohen G, DembIec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970; 34: 30-38.
33. Pinto R, Bartely W. The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in liver homogenates. Biochem J. 1989; 112: 109-15.
34. Bancroft J, Gamble M. Theory and Practice of Histological Techniques. 5th Ed, Edinburgh. Churchill Livingstone Pub., 2002; pp 172-5.
35. Hua G, Ya-wei Z. Inhibitory effect of picroside II on hepatocyte apoptosis. Acta Pharmacology Sin. 2005; 26: 729-36.
36. Rao M, Blane K, Zonneberg M. PC-STAT one and two way analysis of variance. The University of Georgia. Programs. Version 1A (C) copyright. 1985.
37. Abd El-Aziz M, Othman A, Amer M, El-missiry M. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats. J Appl Toxicol. 2001; 21: 469-473.
38. Valko M, Morris H, Cronin M. Toxicity and oxidative stress. Curr Med Chem. 2005; 12: 1161-1208.
39. Valdo M, Lei fritz D, Moncol J, Cronin M, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Brioche Cell. 2007; 39: 49-84.
40. Ben-Shaul V, Lomnitski L, Nyska A, Zurovsky Y, Bergman M, Grossman S. The effect of natural antioxidants NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett. 2001; 123(1): 1-10.
41. Abdel-Wahab M, El-Mahd M, Abd-Ellah M, Helal G, Khalifa F, Hamada F. Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rats heart. Pharmacol Res. 2003; 48(5): 461-465.
42. Reddy N, Reddy S, Rao R. Studies on the effect of doxorubicin on MDA, NO2, NO3, Se-GSH peroxidase and SOD levels in albino rat tissues. Afric J Biochem. 2007; 6(20): 2303-9.
43. Sayed-Ahmed M, Khattab M, Gad M, Osman A. Increased plasma endothelium-1 and cardiac nitric oxide during cardiomyopathy. Pharmacol Toxicol. 2001; 89: 140-144.
44. Pacher P, Liaudet L, Bai P. Potent metalloprophyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation. 2003; 107 (6): 896-904.
45. Nussler A, Di-Silvio M, Liu Z, Geller D, Freeswick P, Dorko K. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology. 1995; 21: 1552-60.
46. Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal B. Evidence that activation of nuclear factor-KB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol. 2004; 67(2): 353-64.
47. Pedrycz A, Boratynski Z, Wieczorski M, Visconti J. Ultrastructural and immunohistochemical evaluation of apoptosis in foetal rat liver after adriamycin administration. Bull Vet Inst Pulawy. 2005; 49: 475-8.
48. Tsamandas A, Thomopoulos K, Zolota V, Kourelis T, Karatzas T, Ravazoula P, Tepetes K, Petsas T. Potential role of Bcl-2 and Bax m-RNA and protein expression in chronic hepatitis type B and C: A clinicopathologic study. Mod Pathol. 2003; 16: 1237-88.
49. Wang L, Ma W, Markovich R, Chen J, Wang P. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor 1. Circ Res. 1998; 83: 516-22.
50. Antunes L, Takahashi C. Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res. 1998; 419: 137-43.
51. Kalaiselvi P, Pragasam V, Srinivasan C, Veena C, Sundarapandiyan R, Palaninathan D. Counteracting adriamycin-induced oxidative stress after administration of N-acetyl cysteine and vitamin E. Clinic Chem Lab. Medicine 2005; 43(8): 834-40.
52. Galli G, Fratelli M. Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: Inhibition by L-Acetyl-Carnitine. Exp Cell Res. 1993; 204: 54-60.
53. Revoltella R, Dal-Canto B, Caracciolo I, D'Urso C. L-Carnitine and some of its analogs delay the onset of apoptotic cell death intiated in murine C28 hepatocytic cells after hepatocytes growth factor deprivation. Biochem Biophys Acta.1994; 1224: 331-41.
54. Di-Mrzio L, Alesse E, Roncaioli P, Muzi P, Morettis S, Marcellini S, Amicosante G. Influence of l-carnitine on CD95 cross-linking -induced apoptosis and ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral sphingomyelinates in vitro. Proc Assoc Am Physicians 1997; 109: 154-63.
55. Geoffroy M, Lambelet P, Richert P. Radical intermediates and antioxidants: an ESR study of radical acid in the presence of radicals formed in carnosoic acid in oxidized lipids. Free Radical Res. 1989; 21(4): 247-58.
56. Al-Sereiti M, Sen P, Abu-Amer K. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Ind Exp Biol. 1999; 37(2): 124-30.
57. Sotelo-Felix J, Martinez-Fong D, Muriel P, Santillan R, Castillo J. Evaluation of the effectiveness of Rosmarinus officinalis (Lamiceae) against alleviation of carbon tetrachloride-induced acute hepatotoxicity. J Ethnopharmacol. 2002; 81(2): 145-54.
58. Amin A, Hamza A. Hepatoprotective effects of Hibiscus, Rosmarinus and Salvia on azathioprine-induced toxicity in rats. Life Sciences 2005; 77: 266-78.
59. Lamaison J, Petitjean-Freytet C, Carnat A. Rosmarinic acid, total hydroxycinnamic derivatives and antioxidant activity of Apiaceae, Borranginaceae and Lamiceae medicinalis. Annales Pharmaceutiques Francaises 1990; 48: 103-108.
60. Haraguchi H, Saito T, Okamura N, Yagi A. Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis. Planta medica, 1995; 61: 333-6.
61. Munne-Bosch S, Schwarz K, Alegre L. Enhanced formation of alpha-tocopherol and highly oxidized obietance diterpenes in water-stressed rosemary plants. Plant Physiol. 1999; 121: 1047-52.
62. Fahim F, Esmat A, Fadel H, Hassan K. Allied studies on the effect of Rosmarinus officinalis L. on experimental hepatotoxicity and mutagenesis. J. Food Sci. Nut. 1999; 50: 413-27.
63. Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7, 12-dimethylbenz [a] anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett. 1996; 104: 43-8.
64. Babu U. Effect of dietary rosemary extract on cell-mediated immunity. Plant Food Hum Nutr. 1996; 53(2): 169-74.